(Q54374397)

28 May 2018

title

Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab. (English)

1 reference

28 May 2018

1 reference

9

1 reference

28 May 2018

Valeria Pietropaolo

10

1 reference

28 May 2018

Federica Ferrari

Federica Ferrari

3

0 references

Giovanni Di Nardo

Giovanni Di Nardo

4

0 references

Fernanda Chiarini

8

Fernanda Chiarini

1 reference

28 May 2018

Anna Bellizzi

1

Anna Bellizzi

1 reference

28 May 2018

Elena Anzivino

2

Elena Anzivino

1 reference

28 May 2018

Monica Mischitelli

7

Monica Mischitelli

1 reference

28 May 2018

Daniela Fioriti

6

Daniela Fioriti

1 reference

28 May 2018

author name string

Maria Teresa Colosimo

5

1 reference

28 May 2018

publication date

6 May 2011

1 reference

28 May 2018

published in

Journal of NeuroVirology

1 reference

28 May 2018

volume

17

1 reference

28 May 2018

issue

4

1 reference

28 May 2018

page(s)

303-313

1 reference

28 May 2018

Genotypes of JC virus in East, Central and Southwest Europe

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Treatment of luminal and fistulizing Crohn's disease with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Polyomaviruses BK- And JC-DNA quantitation in kidney allograft biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Comparison between prospective and retrospective evaluation of Crohn's disease activity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

The safety and side effects of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Avoiding false positives with PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Reemergence of PML in natalizumab-treated patients--new cases, same concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Evolving paradigms in the pathogenesis of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Rearrangement patterns of JC virus noncoding control region from different biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

JC virus infection in allograft kidneys: analysis by polymerase chain reaction and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Transcending conventional therapies: the role of biologic and other novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Biologic therapy of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

The Ets protein Spi-B is expressed exclusively in B cells and T cells during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-011-0036-3

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients

21 January 2018

1 reference

12 December 2020

Human polyomavirus JC virus genome

1 reference

12 December 2020

Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.

1 reference

12 December 2020

Infliximab and the risk of latent viruses reactivation in active Crohn's disease

1 reference

12 December 2020

Viral infection in bone marrow transplants: Is JC virus involved?

1 reference

12 December 2020

Nucleotide sequence of the region encompassing the JC virus origin of DNA replication

1 reference

12 December 2020

PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals.

1 reference

12 December 2020

10.1007/S13365-011-0036-3

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018